BISANTRENE IN ADVANCED, HORMONE-RESISTANT CARCINOMA OF THE PROSTATE - AN ILLINOIS-CANCER-COUNCIL PHASE-II STUDY

被引：0
|
作者：
VOGELZANG, NJ
LANZOTTI, VJ
MUNTEAN, B
BLOUGH, RR
机构：
[1] UNIV CHICAGO HOSP & CLIN,CHICAGO,IL 60637
[2] SO ILLINOIS UNIV,SCH MED,SPRINGFIELD,IL 62708
[3] ILLINOIS CANC COUNCIL,CHICAGO,IL
来源：
INVESTIGATIONAL NEW DRUGS | 1990年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：313 / 315
页数：3
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF BISANTRENE FOR METASTATIC MELANOMA - AN ILLINOIS-CANCER-COUNCIL STUDY
    STIFF, PJ
    SWEET, D
    KILTON, LJ
    JOHNSON, CM
    MUNTEAN, B
    BLOUGH, RR
    MEDICAL AND PEDIATRIC ONCOLOGY, 1991, 19 (02): : 126 - 128
  • [2] PHASE-II TRIAL OF ECHINOMYCIN IN ADVANCED HORMONE-RESISTANT PROSTATE-CANCER
    SHEVRIN, DH
    LAD, TE
    GUINAN, P
    KILTON, LJ
    GREENBURG, A
    JOHNSON, P
    BLOUGH, RR
    HOYER, H
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (01) : 65 - 66
  • [3] PHASE-II STUDY OF ESORUBICIN IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA AND NO PRIOR CHEMOTHERAPY - AN ILLINOIS-CANCER-COUNCIL TRIAL
    LOCKER, GY
    HOELTGEN, T
    KILTON, L
    KRAUSS, S
    MCNAMARA, M
    BLOUGH, R
    JOHNSON, C
    CANCER TREATMENT REPORTS, 1987, 71 (7-8): : 765 - 766
  • [4] PHASE-II STUDY OF EPIRUBICIN IN ADVANCED HORMONE-RESISTANT PROSTATIC-CARCINOMA
    DELAERE, KPJ
    LELIEFELD, H
    PEULEN, F
    STAPPER, EW
    SMEETS, J
    WILS, J
    BRITISH JOURNAL OF UROLOGY, 1992, 70 (06): : 641 - 642
  • [5] PHASE-II TRIAL OF AMINOTHIADIAZOLE IN PREVIOUSLY TREATED AND UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA - AN ILLINOIS-CANCER-COUNCIL TRIAL
    LOCKER, GY
    KHANDEKAR, J
    KRAUSS, S
    REISEL, H
    HOELTGEN, T
    WOLTER, J
    HAID, M
    HOFFMAN, R
    BLOUGH, R
    JOHNSON, C
    CANCER TREATMENT REPORTS, 1987, 71 (06): : 649 - 650
  • [6] PHASE-II TRIAL OF TENIPOSIDE IN PREVIOUSLY TREATED AND UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA - AN ILLINOIS-CANCER-COUNCIL TRIAL
    LOCKER, GY
    LANZOTTI, V
    KHANDEKAR, JD
    SWEET, D
    SHAW, J
    BITRAN, J
    GORDON, L
    KRAUSS, S
    JOHNSON, C
    CANCER TREATMENT REPORTS, 1986, 70 (02): : 307 - 308
  • [7] MITOMYCIN-C TREATMENT OF ADVANCED, HORMONE-RESISTANT PROSTATIC-CARCINOMA - A PHASE-II STUDY
    VERONESI, A
    DALBO, V
    LORE, G
    DELLAVALENTINA, M
    TIRELLI, U
    MERLO, A
    TALAMINI, R
    FRANCINI, M
    MONFARDINI, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (02) : 115 - 116
  • [8] PHASE-II TRIAL OF BISANTRENE FOR UNRESECTABLE NON-SMALL CELL BRONCHOGENIC-CARCINOMA - AN ILLINOIS CANCER COUNCIL STUDY
    MCGUIRE, WP
    BLOUGH, RR
    COBLEIGH, MA
    JOHNSON, CM
    KUKLA, LJ
    LAD, TE
    LANZOTTI, VJ
    STIFF, PJ
    ZAWILA, P
    CANCER TREATMENT REPORTS, 1983, 67 (09): : 841 - 842
  • [9] PHASE-II TRIAL OF MITOLACTOL IN PREVIOUSLY TREATED AND UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CANCER - AN ILLINOIS-CANCER-COUNCIL TRIAL
    LOCKER, GY
    LANZOTTI, V
    SWEET, D
    LAD, T
    KHANDEKAR, J
    STIFF, P
    JOHNSON, C
    MILLER, S
    CANCER TREATMENT REPORTS, 1984, 68 (10): : 1303 - 1304
  • [10] AZIRIDINYLBENZOQUINONE IN RECURRENT, PROGRESSIVE GLIOMA OF THE CENTRAL NERVOUS-SYSTEM - A PHASE-II STUDY BY THE ILLINOIS-CANCER-COUNCIL
    HAID, M
    KHANDEKAR, JD
    CHRIST, M
    JOHNSON, CM
    MILLER, SJ
    LOCKER, GY
    MERRILL, JM
    REISEL, H
    HATFIELD, A
    LANZOTTI, V
    STIFF, P
    SHAW, J
    KRAUSS, S
    SHOWEL, J
    BLOUGH, R
    GORDON, L
    CANCER, 1985, 56 (06) : 1311 - 1315
12345